Literature DB >> 6724621

Altered growth properties of normal human cells induced by phorbol 12,13-didecanoate.

R W Trewyn, H B Gatz.   

Abstract

The tumor promoter phorbol 12,13-didecanoate (PDD) significantly altered the growth properties of early passage normal human skin cells in vitro in culture medium supplemented with elevated concentrations of selected amino acids. Continuous treatment of cells with 10(-7) or 10(-8) M PDD resulted in a 5 to 10-fold increase in saturation density at early passages followed by a long-term two- to fourfold increase. The PDD-treated cultures remained in exponential growth at cell densities greater than 10-fold higher than the control cultures. Removal of PDD from the culture medium while the cells were at a high cell density resulted in a return to near-normal saturation density by the subsequent passage. Anchorage independent growth of normal human cells in methylcellulose was also promoted by PDD in a dose dependent manner, with prior subculturing in the presence of PDD being required for maximal colony formation. The structural analog 4 alpha-phorbol 12,13-didecanoate failed to elicit similar cellular responses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6724621     DOI: 10.1007/BF02619587

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  18 in total

1.  Regulation of gene expression by tumor promoters. II. Control of cell shape and developmental programs for macrophages and granulocytes in human myeloid leukemic cells.

Authors:  D Liebermann; B Hoffman-Liebermann; L Sachs
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

2.  The effect of phorbol esters on the proliferation of C3H-10T 1/2 mouse fibroblasts: consideration of both stimulatory and inhibitory effects.

Authors:  L D Tomei; J C Cheney; C E Wenner
Journal:  J Cell Physiol       Date:  1981-06       Impact factor: 6.384

3.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.

Authors:  G Rovera; D Santoli; C Damsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

4.  Tumor promoters and epidermal growth factor stimulate anchorage-independent growth of adenovirus-tranformed rat embryo cells.

Authors:  P B Fisher; J H Bozzone; I B Weinstein
Journal:  Cell       Date:  1979-11       Impact factor: 41.582

5.  Effects of 12-O-tetradecanoyl phorbol-13-acetate and epidermal growth factor on the proliferation of human mutant fibroblasts in vitro.

Authors:  T Gansler; L Kopelovich
Journal:  Cancer Lett       Date:  1981-09       Impact factor: 8.679

6.  Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells.

Authors:  S Mondal; D W Brankow; C Heidelberger
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

7.  Early effects of the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate on the cell cycle traverse of asynchronous HeLa cells.

Authors:  V Kinzel; J Richards; M Stöhr
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

8.  Tumour promoter alone induces neoplastic transformation of fibroblasts from humans genetically predisposed to cancer.

Authors:  L Kopelovich; N E Bias; L Helson
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

Review 9.  Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes.

Authors:  I B Weinstein; L S Lee; P B Fisher; A Mufson; H Yamasaki
Journal:  J Supramol Struct       Date:  1979

10.  Effects of 12-O-tetradecanoylphorbol-13-acetate on fibroblasts from individuals genetically predisposed to cancer.

Authors:  M H Antecol; B B Mukherjee
Journal:  Cancer Res       Date:  1982-09       Impact factor: 12.701

View more
  1 in total

Review 1.  The queuine micronutrient: charting a course from microbe to man.

Authors:  Claire Fergus; Dominic Barnes; Mashael A Alqasem; Vincent P Kelly
Journal:  Nutrients       Date:  2015-04-15       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.